Glycated hemoglobin measurement and prediction of cardiovascular disease

E. Di Angelantonio; P. Gao; H. Khan; A.S. Butterworth; D. Wormser; S.K. Kaptoge; S.R. Kondapally Seshasai; A. Thompson; N. Sarwar; P. Willeit; P.M. Ridker; E.L.M. Barr; K.T.T. Khaw; B.M. Psaty; H. Brenner; B.J. Balkau; J.M. Dekker; D.A. Lawlor; M. Daimon; J. Willeit; I. Njølstad; A.M. Nissinen; E.J. Brunner; L.H. Kuller; J.F. Price; J. Sundström; Matthew Knuiman; E.J.M. Feskens; W.M.M. Verschuren; N.J. Wald; S.J.L. Bakker; P.H. Whincup; I. Ford; U. Goldbourt; A. Gómez De La Cámara; J.E.J. Gallacher; L.A. Simons; A. Rosengren; S.E. Sutherland; C.V. Björkelund; D.G. Blazer; S.M. Wassertheil-Smoller; A. Onat; A. Marín Ibáñez; E. Casiglia; J.W. Jukema; L.M. Simpson; S. Giampaoli; B.G. Nørdestgaard; R.M. Selmer; P. Wennberg; J. Kauhanen; J.T. Salonen; R.S. Dankner; E.L. Barrett- Connor; M. Kavousi; V.G. Gudnason; D.A. Evans; R.B. Wallace; M. Cushman; R.B. D'Agostino; J.G. Umans; Y. Kiyohara; H. Nakagawa; S. Sato; R.F. Gillum; A.R. Folsom; Y.T. Van Der Schouw; K.G.M. Moons; S.J. Griffin; N.A. Sattar; N.J. Wareham; E. Selvin; S.G. Thompson; J.N. Danesh

doi:10.1001/jama.2014.1873

Glycated hemoglobin measurement and prediction of cardiovascular disease

E. Di Angelantonio
, P. Gao
, H. Khan
, A.S. Butterworth
, D. Wormser
, S.K. Kaptoge
, S.R. Kondapally Seshasai
, A. Thompson
, N. Sarwar
, P. Willeit
, P.M. Ridker
, E.L.M. Barr
, K.T.T. Khaw
, B.M. Psaty
, H. Brenner
, B.J. Balkau
, J.M. Dekker
, D.A. Lawlor
, M. Daimon
, J. Willeit

I. Njølstad, A.M. Nissinen, E.J. Brunner, L.H. Kuller, J.F. Price, J. Sundström, Matthew Knuiman, E.J.M. Feskens, W.M.M. Verschuren, N.J. Wald, S.J.L. Bakker, P.H. Whincup, I. Ford, U. Goldbourt, A. Gómez De La Cámara, J.E.J. Gallacher, L.A. Simons, A. Rosengren, S.E. Sutherland, C.V. Björkelund, D.G. Blazer, S.M. Wassertheil-Smoller, A. Onat, A. Marín Ibáñez, E. Casiglia, J.W. Jukema, L.M. Simpson, S. Giampaoli, B.G. Nørdestgaard, R.M. Selmer, P. Wennberg, J. Kauhanen, J.T. Salonen, R.S. Dankner, E.L. Barrett- Connor, M. Kavousi, V.G. Gudnason, D.A. Evans, R.B. Wallace, M. Cushman, R.B. D'Agostino, J.G. Umans, Y. Kiyohara, H. Nakagawa, S. Sato, R.F. Gillum, A.R. Folsom, Y.T. Van Der Schouw, K.G.M. Moons, S.J. Griffin, N.A. Sattar, N.J. Wareham, E. Selvin, S.G. Thompson, J.N. Danesh

Research output: Contribution to journal › Article › peer-review

198 Citations (Scopus)

Abstract

IMPORTANCE: The value of measuring levels of glycated hemoglobin (HbA 1c) for the prediction of first cardiovascular events is uncertain. OBJECTIVE: To determine whether adding information on HbA1c values to conventional cardiovascular risk factors is associated with improvement in prediction of cardiovascular disease (CVD) risk. DESIGN, SETTING, AND PARTICIPANTS: Analysis of individual-participant data available from 73 prospective studies involving 294 998 participants without a known history of diabetes mellitus or CVD at the baseline assessment. MAIN OUTCOMES AND MEASURES: Measures of risk discrimination for CVD outcomes (eg, C-index) and reclassification (eg, net reclassification improvement) of participants across predicted 10-year risk categories of low (

Original language	English
Pages (from-to)	1225-1233
Journal	JAMA: The Journal of the American Medical Association
Volume	311
Issue number	12
DOIs	https://doi.org/10.1001/jama.2014.1873
Publication status	Published - 2014

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1001/jama.2014.1873

Cite this

Di Angelantonio, E., Gao, P., Khan, H., Butterworth, A. S., Wormser, D., Kaptoge, S. K., Kondapally Seshasai, S. R., Thompson, A., Sarwar, N., Willeit, P., Ridker, P. M., Barr, E. L. M., Khaw, K. T. T., Psaty, B. M., Brenner, H., Balkau, B. J., Dekker, J. M., Lawlor, D. A., Daimon, M., ... Danesh, J. N. (2014). Glycated hemoglobin measurement and prediction of cardiovascular disease. JAMA: The Journal of the American Medical Association, 311(12), 1225-1233. https://doi.org/10.1001/jama.2014.1873

@article{f9492fd241274ae6890d49f6107d98bd,

title = "Glycated hemoglobin measurement and prediction of cardiovascular disease",

abstract = "IMPORTANCE: The value of measuring levels of glycated hemoglobin (HbA 1c) for the prediction of first cardiovascular events is uncertain. OBJECTIVE: To determine whether adding information on HbA1c values to conventional cardiovascular risk factors is associated with improvement in prediction of cardiovascular disease (CVD) risk. DESIGN, SETTING, AND PARTICIPANTS: Analysis of individual-participant data available from 73 prospective studies involving 294 998 participants without a known history of diabetes mellitus or CVD at the baseline assessment. MAIN OUTCOMES AND MEASURES: Measures of risk discrimination for CVD outcomes (eg, C-index) and reclassification (eg, net reclassification improvement) of participants across predicted 10-year risk categories of low (",

author = "\{Di Angelantonio\}, E. and P. Gao and H. Khan and A.S. Butterworth and D. Wormser and S.K. Kaptoge and \{Kondapally Seshasai\}, S.R. and A. Thompson and N. Sarwar and P. Willeit and P.M. Ridker and E.L.M. Barr and K.T.T. Khaw and B.M. Psaty and H. Brenner and B.J. Balkau and J.M. Dekker and D.A. Lawlor and M. Daimon and J. Willeit and I. Nj{\o}lstad and A.M. Nissinen and E.J. Brunner and L.H. Kuller and J.F. Price and J. Sundstr{\"o}m and Matthew Knuiman and E.J.M. Feskens and W.M.M. Verschuren and N.J. Wald and S.J.L. Bakker and P.H. Whincup and I. Ford and U. Goldbourt and \{G{\'o}mez De La C{\'a}mara\}, A. and J.E.J. Gallacher and L.A. Simons and A. Rosengren and S.E. Sutherland and C.V. Bj{\"o}rkelund and D.G. Blazer and S.M. Wassertheil-Smoller and A. Onat and \{Mar{\'i}n Ib{\'a}{\~n}ez\}, A. and E. Casiglia and J.W. Jukema and L.M. Simpson and S. Giampaoli and B.G. N{\o}rdestgaard and R.M. Selmer and P. Wennberg and J. Kauhanen and J.T. Salonen and R.S. Dankner and \{Barrett- Connor\}, E.L. and M. Kavousi and V.G. Gudnason and D.A. Evans and R.B. Wallace and M. Cushman and R.B. D'Agostino and J.G. Umans and Y. Kiyohara and H. Nakagawa and S. Sato and R.F. Gillum and A.R. Folsom and \{Van Der Schouw\}, Y.T. and K.G.M. Moons and S.J. Griffin and N.A. Sattar and N.J. Wareham and E. Selvin and S.G. Thompson and J.N. Danesh",

year = "2014",

doi = "10.1001/jama.2014.1873",

language = "English",

volume = "311",

pages = "1225--1233",

journal = "JAMA: The Journal of the American Medical Association",

issn = "0098-7484",

publisher = "American Medical Association",

number = "12",

}

Di Angelantonio, E, Gao, P, Khan, H, Butterworth, AS, Wormser, D, Kaptoge, SK, Kondapally Seshasai, SR, Thompson, A, Sarwar, N, Willeit, P, Ridker, PM, Barr, ELM, Khaw, KTT, Psaty, BM, Brenner, H, Balkau, BJ, Dekker, JM, Lawlor, DA, Daimon, M, Willeit, J, Njølstad, I, Nissinen, AM, Brunner, EJ, Kuller, LH, Price, JF, Sundström, J, Knuiman, M, Feskens, EJM, Verschuren, WMM, Wald, NJ, Bakker, SJL, Whincup, PH, Ford, I, Goldbourt, U, Gómez De La Cámara, A, Gallacher, JEJ, Simons, LA, Rosengren, A, Sutherland, SE, Björkelund, CV, Blazer, DG, Wassertheil-Smoller, SM, Onat, A, Marín Ibáñez, A, Casiglia, E, Jukema, JW, Simpson, LM, Giampaoli, S, Nørdestgaard, BG, Selmer, RM, Wennberg, P, Kauhanen, J, Salonen, JT, Dankner, RS, Barrett- Connor, EL, Kavousi, M, Gudnason, VG, Evans, DA, Wallace, RB, Cushman, M, D'Agostino, RB, Umans, JG, Kiyohara, Y, Nakagawa, H, Sato, S, Gillum, RF, Folsom, AR, Van Der Schouw, YT, Moons, KGM, Griffin, SJ, Sattar, NA, Wareham, NJ, Selvin, E, Thompson, SG & Danesh, JN 2014, 'Glycated hemoglobin measurement and prediction of cardiovascular disease', JAMA: The Journal of the American Medical Association, vol. 311, no. 12, pp. 1225-1233. https://doi.org/10.1001/jama.2014.1873

TY - JOUR

T1 - Glycated hemoglobin measurement and prediction of cardiovascular disease

AU - Di Angelantonio, E.

AU - Gao, P.

AU - Khan, H.

AU - Butterworth, A.S.

AU - Wormser, D.

AU - Kaptoge, S.K.

AU - Kondapally Seshasai, S.R.

AU - Thompson, A.

AU - Sarwar, N.

AU - Willeit, P.

AU - Ridker, P.M.

AU - Barr, E.L.M.

AU - Khaw, K.T.T.

AU - Psaty, B.M.

AU - Brenner, H.

AU - Balkau, B.J.

AU - Dekker, J.M.

AU - Lawlor, D.A.

AU - Daimon, M.

AU - Willeit, J.

AU - Njølstad, I.

AU - Nissinen, A.M.

AU - Brunner, E.J.

AU - Kuller, L.H.

AU - Price, J.F.

AU - Sundström, J.

AU - Knuiman, Matthew

AU - Feskens, E.J.M.

AU - Verschuren, W.M.M.

AU - Wald, N.J.

AU - Bakker, S.J.L.

AU - Whincup, P.H.

AU - Ford, I.

AU - Goldbourt, U.

AU - Gómez De La Cámara, A.

AU - Gallacher, J.E.J.

AU - Simons, L.A.

AU - Rosengren, A.

AU - Sutherland, S.E.

AU - Björkelund, C.V.

AU - Blazer, D.G.

AU - Wassertheil-Smoller, S.M.

AU - Onat, A.

AU - Marín Ibáñez, A.

AU - Casiglia, E.

AU - Jukema, J.W.

AU - Simpson, L.M.

AU - Giampaoli, S.

AU - Nørdestgaard, B.G.

AU - Selmer, R.M.

AU - Wennberg, P.

AU - Kauhanen, J.

AU - Salonen, J.T.

AU - Dankner, R.S.

AU - Barrett- Connor, E.L.

AU - Kavousi, M.

AU - Gudnason, V.G.

AU - Evans, D.A.

AU - Wallace, R.B.

AU - Cushman, M.

AU - D'Agostino, R.B.

AU - Umans, J.G.

AU - Kiyohara, Y.

AU - Nakagawa, H.

AU - Sato, S.

AU - Gillum, R.F.

AU - Folsom, A.R.

AU - Van Der Schouw, Y.T.

AU - Moons, K.G.M.

AU - Griffin, S.J.

AU - Sattar, N.A.

AU - Wareham, N.J.

AU - Selvin, E.

AU - Thompson, S.G.

AU - Danesh, J.N.

PY - 2014

Y1 - 2014

N2 - IMPORTANCE: The value of measuring levels of glycated hemoglobin (HbA 1c) for the prediction of first cardiovascular events is uncertain. OBJECTIVE: To determine whether adding information on HbA1c values to conventional cardiovascular risk factors is associated with improvement in prediction of cardiovascular disease (CVD) risk. DESIGN, SETTING, AND PARTICIPANTS: Analysis of individual-participant data available from 73 prospective studies involving 294 998 participants without a known history of diabetes mellitus or CVD at the baseline assessment. MAIN OUTCOMES AND MEASURES: Measures of risk discrimination for CVD outcomes (eg, C-index) and reclassification (eg, net reclassification improvement) of participants across predicted 10-year risk categories of low (

AB - IMPORTANCE: The value of measuring levels of glycated hemoglobin (HbA 1c) for the prediction of first cardiovascular events is uncertain. OBJECTIVE: To determine whether adding information on HbA1c values to conventional cardiovascular risk factors is associated with improvement in prediction of cardiovascular disease (CVD) risk. DESIGN, SETTING, AND PARTICIPANTS: Analysis of individual-participant data available from 73 prospective studies involving 294 998 participants without a known history of diabetes mellitus or CVD at the baseline assessment. MAIN OUTCOMES AND MEASURES: Measures of risk discrimination for CVD outcomes (eg, C-index) and reclassification (eg, net reclassification improvement) of participants across predicted 10-year risk categories of low (

U2 - 10.1001/jama.2014.1873

DO - 10.1001/jama.2014.1873

M3 - Article

SN - 0098-7484

VL - 311

SP - 1225

EP - 1233

JO - JAMA: The Journal of the American Medical Association

JF - JAMA: The Journal of the American Medical Association

IS - 12

ER -

Glycated hemoglobin measurement and prediction of cardiovascular disease

Abstract

UN SDGs

Access to Document

Fingerprint

Cite this